Advertisements


Mark Cuban Picks These 2 Cryptocurrencies For The Most Upside

One of the most vocal bulls of Dogecoin (CRYPTO: DOGE) in 2021 has been Mark Cuban. The Dallas Mavericks began accepting Dogecoin as a form of payment for tickets and merch earlier this year, but DOGE might not be Cuban’s favorite cryptocurrency anymore. read more.....»»

Category: blogSource: benzingaOct 13th, 2021

Boeing (BA) Stock Sinks As Market Gains: What You Should Know

Boeing (BA) closed the most recent trading day at $221.78, moving -0.8% from the previous trading session. Boeing (BA) closed the most recent trading day at $221.78, moving -0.8% from the previous trading session. This move lagged the S&P 500's daily gain of 0.3%.Prior to today's trading, shares of the airplane builder had gained 5.67% over the past month. This has outpaced the Aerospace sector's gain of 1.13% and the S&P 500's loss of 2.37% in that time.Investors will be hoping for strength from BA as it approaches its next earnings release, which is expected to be October 27, 2021. In that report, analysts expect BA to post earnings of $0.27 per share. This would mark year-over-year growth of 119.42%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $18.52 billion, up 31.01% from the year-ago period.Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of -$0.21 per share and revenue of $74.43 billion. These totals would mark changes of +99.1% and +27.99%, respectively, from last year.Investors might also notice recent changes to analyst estimates for BA. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. BA currently has a Zacks Rank of #3 (Hold).The Aerospace - Defense industry is part of the Aerospace sector. This industry currently has a Zacks Industry Rank of 85, which puts it in the top 34% of all 250+ industries.The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.You can find more information on all of these metrics, and much more, on Zacks.com. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Boeing Company (BA): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksOct 13th, 2021

Salesforce.com (CRM) Outpaces Stock Market Gains: What You Should Know

Salesforce.com (CRM) closed at $284.41 in the latest trading session, marking a +1.94% move from the prior day. In the latest trading session, Salesforce.com (CRM) closed at $284.41, marking a +1.94% move from the previous day. The stock outpaced the S&P 500's daily gain of 0.3%.Coming into today, shares of the customer-management software developer had gained 9.68% in the past month. In that same time, the Computer and Technology sector lost 5.35%, while the S&P 500 lost 2.37%.Wall Street will be looking for positivity from CRM as it approaches its next earnings report date. On that day, CRM is projected to report earnings of $0.92 per share, which would represent a year-over-year decline of 47.13%. Meanwhile, our latest consensus estimate is calling for revenue of $6.79 billion, up 25.27% from the prior-year quarter.Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $4.40 per share and revenue of $26.3 billion. These totals would mark changes of -10.57% and +23.73%, respectively, from last year.Investors might also notice recent changes to analyst estimates for CRM. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 2.82% higher. CRM is holding a Zacks Rank of #1 (Strong Buy) right now.Investors should also note CRM's current valuation metrics, including its Forward P/E ratio of 63.47. This valuation marks a premium compared to its industry's average Forward P/E of 33.68.Investors should also note that CRM has a PEG ratio of 3.79 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Computer - Software industry currently had an average PEG ratio of 2.87 as of yesterday's close.The Computer - Software industry is part of the Computer and Technology sector. This industry currently has a Zacks Industry Rank of 107, which puts it in the top 43% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report salesforce.com, inc. (CRM): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksOct 13th, 2021

Caterpillar (CAT) Stock Sinks As Market Gains: What You Should Know

Caterpillar (CAT) closed at $188.94 in the latest trading session, marking a -0.52% move from the prior day. In the latest trading session, Caterpillar (CAT) closed at $188.94, marking a -0.52% move from the previous day. This change lagged the S&P 500's daily gain of 0.3%.Coming into today, shares of the construction equipment company had lost 6.13% in the past month. In that same time, the Industrial Products sector lost 6.25%, while the S&P 500 lost 2.37%.Wall Street will be looking for positivity from CAT as it approaches its next earnings report date. This is expected to be October 28, 2021. On that day, CAT is projected to report earnings of $2.29 per share, which would represent year-over-year growth of 70.9%. Meanwhile, our latest consensus estimate is calling for revenue of $12.57 billion, up 27.21% from the prior-year quarter.Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $10.16 per share and revenue of $50.59 billion. These totals would mark changes of +54.88% and +21.17%, respectively, from last year.Investors might also notice recent changes to analyst estimates for CAT. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 0.29% higher. CAT is holding a Zacks Rank of #3 (Hold) right now.Investors should also note CAT's current valuation metrics, including its Forward P/E ratio of 18.7. This valuation marks a discount compared to its industry's average Forward P/E of 21.13.Investors should also note that CAT has a PEG ratio of 1.56 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. The Manufacturing - Construction and Mining industry currently had an average PEG ratio of 1.15 as of yesterday's close.The Manufacturing - Construction and Mining industry is part of the Industrial Products sector. This industry currently has a Zacks Industry Rank of 232, which puts it in the bottom 9% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Caterpillar Inc. (CAT): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksOct 13th, 2021

Kroger (KR) Stock Sinks As Market Gains: What You Should Know

Kroger (KR) closed at $39.47 in the latest trading session, marking a -0.9% move from the prior day. Kroger (KR) closed the most recent trading day at $39.47, moving -0.9% from the previous trading session. This move lagged the S&P 500's daily gain of 0.3%.Coming into today, shares of the supermarket chain had lost 4.69% in the past month. In that same time, the Retail-Wholesale sector lost 4.97%, while the S&P 500 lost 2.37%.Wall Street will be looking for positivity from KR as it approaches its next earnings report date. In that report, analysts expect KR to post earnings of $0.65 per share. This would mark a year-over-year decline of 8.45%. Meanwhile, our latest consensus estimate is calling for revenue of $30.87 billion, up 3.86% from the prior-year quarter.For the full year, our Zacks Consensus Estimates are projecting earnings of $3.33 per share and revenue of $135.59 billion, which would represent changes of -4.03% and +2.33%, respectively, from the prior year.Investors might also notice recent changes to analyst estimates for KR. These recent revisions tend to reflect the evolving nature of short-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 0.38% higher. KR is currently sporting a Zacks Rank of #1 (Strong Buy).Investors should also note KR's current valuation metrics, including its Forward P/E ratio of 11.98. Its industry sports an average Forward P/E of 13.52, so we one might conclude that KR is trading at a discount comparatively.Also, we should mention that KR has a PEG ratio of 1.34. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Retail - Supermarkets was holding an average PEG ratio of 1.13 at yesterday's closing price.The Retail - Supermarkets industry is part of the Retail-Wholesale sector. This industry currently has a Zacks Industry Rank of 27, which puts it in the top 11% of all 250+ industries.The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report The Kroger Co. (KR): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksOct 13th, 2021

MasterCard (MA) Stock Sinks As Market Gains: What You Should Know

In the latest trading session, MasterCard (MA) closed at $342.35, marking a -0.87% move from the previous day. MasterCard (MA) closed at $342.35 in the latest trading session, marking a -0.87% move from the prior day. This change lagged the S&P 500's daily gain of 0.3%.Prior to today's trading, shares of the processor of debit and credit card payments had lost 0.13% over the past month. This has was narrower than the Business Services sector's loss of 6.77% and the S&P 500's loss of 2.37% in that time.MA will be looking to display strength as it nears its next earnings release, which is expected to be October 28, 2021. In that report, analysts expect MA to post earnings of $2.18 per share. This would mark year-over-year growth of 36.25%. Our most recent consensus estimate is calling for quarterly revenue of $4.95 billion, up 29.12% from the year-ago period.Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $8.11 per share and revenue of $18.81 billion. These totals would mark changes of +26.13% and +22.9%, respectively, from last year.It is also important to note the recent changes to analyst estimates for MA. These revisions typically reflect the latest short-term business trends, which can change frequently. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.01% higher. MA is currently a Zacks Rank #2 (Buy).Looking at its valuation, MA is holding a Forward P/E ratio of 42.6. For comparison, its industry has an average Forward P/E of 19.9, which means MA is trading at a premium to the group.Meanwhile, MA's PEG ratio is currently 1.97. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. The Financial Transaction Services was holding an average PEG ratio of 1.2 at yesterday's closing price.The Financial Transaction Services industry is part of the Business Services sector. This industry currently has a Zacks Industry Rank of 69, which puts it in the top 28% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.You can find more information on all of these metrics, and much more, on Zacks.com. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Mastercard Incorporated (MA): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksOct 13th, 2021

Regeneron (REGN) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Regeneron (REGN) closed at $547.12, marking a +0.49% move from the previous day. In the latest trading session, Regeneron (REGN) closed at $547.12, marking a +0.49% move from the previous day. This change outpaced the S&P 500's 0.3% gain on the day.Prior to today's trading, shares of the biopharmaceutical company had lost 15.61% over the past month. This has lagged the Medical sector's loss of 6.61% and the S&P 500's loss of 2.37% in that time.Wall Street will be looking for positivity from REGN as it approaches its next earnings report date. This is expected to be November 4, 2021. In that report, analysts expect REGN to post earnings of $9.54 per share. This would mark year-over-year growth of 14.11%. Meanwhile, our latest consensus estimate is calling for revenue of $2.6 billion, up 13.31% from the prior-year quarter.For the full year, our Zacks Consensus Estimates are projecting earnings of $61.50 per share and revenue of $13.92 billion, which would represent changes of +95.42% and +63.79%, respectively, from the prior year.Investors might also notice recent changes to analyst estimates for REGN. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.Research indicates that these estimate revisions are directly correlated with near-term share price momentum. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. The Zacks Consensus EPS estimate has moved 12.96% higher within the past month. REGN is holding a Zacks Rank of #1 (Strong Buy) right now.Looking at its valuation, REGN is holding a Forward P/E ratio of 8.85. This valuation marks a discount compared to its industry's average Forward P/E of 23.5.Investors should also note that REGN has a PEG ratio of 1.04 right now. The PEG ratio is similar to the widely-used P/E ratio, but this metric also takes the company's expected earnings growth rate into account. REGN's industry had an average PEG ratio of 1.49 as of yesterday's close.The Medical - Biomedical and Genetics industry is part of the Medical sector. This group has a Zacks Industry Rank of 170, putting it in the bottom 34% of all 250+ industries.The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Regeneron Pharmaceuticals, Inc. (REGN): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksOct 13th, 2021

United States Steel (X) Stock Sinks As Market Gains: What You Should Know

United States Steel (X) closed the most recent trading day at $21.45, moving -1.61% from the previous trading session. United States Steel (X) closed the most recent trading day at $21.45, moving -1.61% from the previous trading session. This change lagged the S&P 500's 0.3% gain on the day.Heading into today, shares of the steel maker had lost 10.84% over the past month, lagging the Basic Materials sector's loss of 2.71% and the S&P 500's loss of 2.37% in that time.Investors will be hoping for strength from X as it approaches its next earnings release, which is expected to be October 28, 2021. In that report, analysts expect X to post earnings of $4.56 per share. This would mark year-over-year growth of 476.86%. Our most recent consensus estimate is calling for quarterly revenue of $5.61 billion, up 139.57% from the year-ago period.X's full-year Zacks Consensus Estimates are calling for earnings of $13.04 per share and revenue of $19.68 billion. These results would represent year-over-year changes of +379.23% and +102.07%, respectively.Any recent changes to analyst estimates for X should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 7.1% higher. X is holding a Zacks Rank of #2 (Buy) right now.In terms of valuation, X is currently trading at a Forward P/E ratio of 1.67. For comparison, its industry has an average Forward P/E of 4.27, which means X is trading at a discount to the group.The Steel - Producers industry is part of the Basic Materials sector. This group has a Zacks Industry Rank of 30, putting it in the top 12% of all 250+ industries.The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.To follow X in the coming trading sessions, be sure to utilize Zacks.com. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report United States Steel Corporation (X): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksOct 13th, 2021

ZIM Integrated Shipping Services (ZIM) Stock Sinks As Market Gains: What You Should Know

ZIM Integrated Shipping Services (ZIM) closed the most recent trading day at $45.95, moving -1.42% from the previous trading session. In the latest trading session, ZIM Integrated Shipping Services (ZIM) closed at $45.95, marking a -1.42% move from the previous day. This change lagged the S&P 500's daily gain of 0.3%.Prior to today's trading, shares of the container shipping company had lost 18.4% over the past month. This has lagged the Transportation sector's loss of 2.74% and the S&P 500's loss of 2.37% in that time.ZIM will be looking to display strength as it nears its next earnings release.Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $31.33 per share and revenue of $9.6 billion. These totals would mark changes of +531.65% and +140.56%, respectively, from last year.Any recent changes to analyst estimates for ZIM should also be noted by investors. These revisions help to show the ever-changing nature of near-term business trends. With this in mind, we can consider positive estimate revisions a sign of optimism about the company's business outlook.Based on our research, we believe these estimate revisions are directly related to near-team stock moves. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate has moved 1.77% higher. ZIM is currently sporting a Zacks Rank of #1 (Strong Buy).Digging into valuation, ZIM currently has a Forward P/E ratio of 1.49. This represents a discount compared to its industry's average Forward P/E of 4.62.The Transportation - Shipping industry is part of the Transportation sector. This industry currently has a Zacks Industry Rank of 53, which puts it in the top 21% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.To follow ZIM in the coming trading sessions, be sure to utilize Zacks.com. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report ZIM Integrated Shipping Services Ltd. (ZIM): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksOct 13th, 2021

Activision Blizzard, Inc (ATVI) Outpaces Stock Market Gains: What You Should Know

In the latest trading session, Activision Blizzard, Inc (ATVI) closed at $75.25, marking a +0.44% move from the previous day. Activision Blizzard, Inc (ATVI) closed the most recent trading day at $75.25, moving +0.44% from the previous trading session. This change outpaced the S&P 500's 0.3% gain on the day.Coming into today, shares of the company had lost 3.75% in the past month. In that same time, the Consumer Discretionary sector lost 5.34%, while the S&P 500 lost 2.37%.Wall Street will be looking for positivity from ATVI as it approaches its next earnings report date. This is expected to be November 2, 2021. On that day, ATVI is projected to report earnings of $0.71 per share, which would represent no growth from the year-ago period. Meanwhile, our latest consensus estimate is calling for revenue of $1.88 billion, up 6.4% from the prior-year quarter.Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $3.85 per share and revenue of $8.78 billion. These totals would mark changes of +10.95% and +4.34%, respectively, from last year.Any recent changes to analyst estimates for ATVI should also be noted by investors. These revisions typically reflect the latest short-term business trends, which can change frequently. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.Our research shows that these estimate changes are directly correlated with near-term stock prices. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.The Zacks Rank system, which ranges from #1 (Strong Buy) to #5 (Strong Sell), has an impressive outside-audited track record of outperformance, with #1 stocks generating an average annual return of +25% since 1988. Within the past 30 days, our consensus EPS projection has moved 0.72% higher. ATVI is holding a Zacks Rank of #3 (Hold) right now.Digging into valuation, ATVI currently has a Forward P/E ratio of 19.49. For comparison, its industry has an average Forward P/E of 19.49, which means ATVI is trading at a no noticeable deviation to the group.Meanwhile, ATVI's PEG ratio is currently 1.26. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. The Toys - Games - Hobbies was holding an average PEG ratio of 2.35 at yesterday's closing price.The Toys - Games - Hobbies industry is part of the Consumer Discretionary sector. This group has a Zacks Industry Rank of 182, putting it in the bottom 29% of all 250+ industries.The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Be sure to follow all of these stock-moving metrics, and many more, on Zacks.com. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Activision Blizzard, Inc (ATVI): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksOct 13th, 2021

Bristol Myers Squibb (BMY) Gains But Lags Market: What You Should Know

In the latest trading session, Bristol Myers Squibb (BMY) closed at $57.07, marking a +0.02% move from the previous day. Bristol Myers Squibb (BMY) closed at $57.07 in the latest trading session, marking a +0.02% move from the prior day. This change lagged the S&P 500's 0.3% gain on the day.Coming into today, shares of the biopharmaceutical company had lost 8.13% in the past month. In that same time, the Medical sector lost 6.61%, while the S&P 500 lost 2.37%.Wall Street will be looking for positivity from BMY as it approaches its next earnings report date. This is expected to be October 27, 2021. In that report, analysts expect BMY to post earnings of $1.91 per share. This would mark year-over-year growth of 17.18%. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $11.55 billion, up 9.59% from the year-ago period.BMY's full-year Zacks Consensus Estimates are calling for earnings of $7.48 per share and revenue of $46.34 billion. These results would represent year-over-year changes of +16.15% and +8.98%, respectively.Any recent changes to analyst estimates for BMY should also be noted by investors. Recent revisions tend to reflect the latest near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Research indicates that these estimate revisions are directly correlated with near-term share price momentum. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 0.19% higher. BMY is holding a Zacks Rank of #3 (Hold) right now.Digging into valuation, BMY currently has a Forward P/E ratio of 7.62. Its industry sports an average Forward P/E of 23.5, so we one might conclude that BMY is trading at a discount comparatively.It is also worth noting that BMY currently has a PEG ratio of 1.08. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. Medical - Biomedical and Genetics stocks are, on average, holding a PEG ratio of 1.49 based on yesterday's closing prices.The Medical - Biomedical and Genetics industry is part of the Medical sector. This group has a Zacks Industry Rank of 170, putting it in the bottom 34% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Bristol Myers Squibb Company (BMY): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksOct 13th, 2021

Enterprise Products Partners (EPD) Gains But Lags Market: What You Should Know

In the latest trading session, Enterprise Products Partners (EPD) closed at $24.02, marking a +0.13% move from the previous day. Enterprise Products Partners (EPD) closed the most recent trading day at $24.02, moving +0.13% from the previous trading session. This change lagged the S&P 500's 0.3% gain on the day.Prior to today's trading, shares of the provider of midstream energy services had gained 7.87% over the past month. This has lagged the Oils-Energy sector's gain of 14.29% and outpaced the S&P 500's loss of 2.37% in that time.Investors will be hoping for strength from EPD as it approaches its next earnings release. On that day, EPD is projected to report earnings of $0.52 per share, which would represent year-over-year growth of 8.33%. Our most recent consensus estimate is calling for quarterly revenue of $8.99 billion, up 29.86% from the year-ago period.Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $2.17 per share and revenue of $36.69 billion. These totals would mark changes of +2.84% and +34.88%, respectively, from last year.Investors should also note any recent changes to analyst estimates for EPD. These revisions help to show the ever-changing nature of near-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection has moved 0.4% higher. EPD is holding a Zacks Rank of #4 (Sell) right now.In terms of valuation, EPD is currently trading at a Forward P/E ratio of 11.06. Its industry sports an average Forward P/E of 10.26, so we one might conclude that EPD is trading at a premium comparatively.The Oil and Gas - Production Pipeline - MLB industry is part of the Oils-Energy sector. This group has a Zacks Industry Rank of 215, putting it in the bottom 16% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.You can find more information on all of these metrics, and much more, on Zacks.com. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Enterprise Products Partners L.P. (EPD): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksOct 13th, 2021

Paycom Software (PAYC) Outpaces Stock Market Gains: What You Should Know

Paycom Software (PAYC) closed the most recent trading day at $516.33, moving +1.36% from the previous trading session. Paycom Software (PAYC) closed the most recent trading day at $516.33, moving +1.36% from the previous trading session. This change outpaced the S&P 500's 0.3% gain on the day.Coming into today, shares of the maker of human-resources and payroll software had gained 8.84% in the past month. In that same time, the Computer and Technology sector lost 5.35%, while the S&P 500 lost 2.37%.Investors will be hoping for strength from PAYC as it approaches its next earnings release. In that report, analysts expect PAYC to post earnings of $0.91 per share. This would mark year-over-year growth of 30%. Our most recent consensus estimate is calling for quarterly revenue of $250.37 million, up 27.39% from the year-ago period.PAYC's full-year Zacks Consensus Estimates are calling for earnings of $4.41 per share and revenue of $1.04 billion. These results would represent year-over-year changes of +26.36% and +23.31%, respectively.Investors should also note any recent changes to analyst estimates for PAYC. Recent revisions tend to reflect the latest near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.Our research shows that these estimate changes are directly correlated with near-term stock prices. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.The Zacks Rank system ranges from #1 (Strong Buy) to #5 (Strong Sell). It has a remarkable, outside-audited track record of success, with #1 stocks delivering an average annual return of +25% since 1988. Over the past month, the Zacks Consensus EPS estimate remained stagnant. PAYC currently has a Zacks Rank of #3 (Hold).In terms of valuation, PAYC is currently trading at a Forward P/E ratio of 115.64. This represents a premium compared to its industry's average Forward P/E of 58.45.We can also see that PAYC currently has a PEG ratio of 4.63. This metric is used similarly to the famous P/E ratio, but the PEG ratio also takes into account the stock's expected earnings growth rate. Internet - Software stocks are, on average, holding a PEG ratio of 4.1 based on yesterday's closing prices.The Internet - Software industry is part of the Computer and Technology sector. This group has a Zacks Industry Rank of 170, putting it in the bottom 34% of all 250+ industries.The Zacks Industry Rank gauges the strength of our industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Paycom Software, Inc. (PAYC): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksOct 13th, 2021

Smith & Wesson (SWBI) Gains But Lags Market: What You Should Know

Smith & Wesson (SWBI) closed at $21.04 in the latest trading session, marking a +0.29% move from the prior day. Smith & Wesson (SWBI) closed at $21.04 in the latest trading session, marking a +0.29% move from the prior day. This change lagged the S&P 500's 0.3% gain on the day.Prior to today's trading, shares of the firearm maker had gained 1.55% over the past month. This has outpaced the Consumer Discretionary sector's loss of 5.34% and the S&P 500's loss of 2.37% in that time.Investors will be hoping for strength from SWBI as it approaches its next earnings release. On that day, SWBI is projected to report earnings of $1.37 per share, which would represent year-over-year growth of 47.31%. Our most recent consensus estimate is calling for quarterly revenue of $277.9 million, up 11.73% from the year-ago period.Looking at the full year, our Zacks Consensus Estimates suggest analysts are expecting earnings of $5.05 per share and revenue of $924.3 million. These totals would mark changes of +11.23% and -16.52%, respectively, from last year.It is also important to note the recent changes to analyst estimates for SWBI. These recent revisions tend to reflect the evolving nature of short-term business trends. As such, positive estimate revisions reflect analyst optimism about the company's business and profitability.Based on our research, we believe these estimate revisions are directly related to near-team stock moves. We developed the Zacks Rank to capitalize on this phenomenon. Our system takes these estimate changes into account and delivers a clear, actionable rating model.Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. SWBI is currently a Zacks Rank #3 (Hold).Valuation is also important, so investors should note that SWBI has a Forward P/E ratio of 4.16 right now. This represents a discount compared to its industry's average Forward P/E of 11.4.The Leisure and Recreation Products industry is part of the Consumer Discretionary sector. This industry currently has a Zacks Industry Rank of 43, which puts it in the top 17% of all 250+ industries.The Zacks Industry Rank includes is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.You can find more information on all of these metrics, and much more, on Zacks.com. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Smith & Wesson Brands, Inc. (SWBI): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksOct 13th, 2021

Unity Software Inc. (U) Stock Sinks As Market Gains: What You Should Know

Unity Software Inc. (U) closed the most recent trading day at $137.76, moving -1.06% from the previous trading session. In the latest trading session, Unity Software Inc. (U) closed at $137.76, marking a -1.06% move from the previous day. This change lagged the S&P 500's 0.3% gain on the day.Heading into today, shares of the company had gained 5.7% over the past month, outpacing the Computer and Technology sector's loss of 5.35% and the S&P 500's loss of 2.37% in that time.U will be looking to display strength as it nears its next earnings release, which is expected to be November 9, 2021. In that report, analysts expect U to post earnings of -$0.06 per share. This would mark year-over-year growth of 33.33%. Our most recent consensus estimate is calling for quarterly revenue of $266.14 million, up 32.55% from the year-ago period.For the full year, our Zacks Consensus Estimates are projecting earnings of -$0.23 per share and revenue of $1.06 billion, which would represent changes of +41.03% and +37.41%, respectively, from the prior year.It is also important to note the recent changes to analyst estimates for U. These revisions help to show the ever-changing nature of near-term business trends. As a result, we can interpret positive estimate revisions as a good sign for the company's business outlook.Research indicates that these estimate revisions are directly correlated with near-term share price momentum. To benefit from this, we have developed the Zacks Rank, a proprietary model which takes these estimate changes into account and provides an actionable rating system.Ranging from #1 (Strong Buy) to #5 (Strong Sell), the Zacks Rank system has a proven, outside-audited track record of outperformance, with #1 stocks returning an average of +25% annually since 1988. Within the past 30 days, our consensus EPS projection remained stagnant. U is holding a Zacks Rank of #3 (Hold) right now.The Internet - Software industry is part of the Computer and Technology sector. This industry currently has a Zacks Industry Rank of 170, which puts it in the bottom 34% of all 250+ industries.The Zacks Industry Rank gauges the strength of our individual industry groups by measuring the average Zacks Rank of the individual stocks within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.Make sure to utilize Zacks. Com to follow all of these stock-moving metrics, and more, in the coming trading sessions. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Unity Software Inc. (U): Free Stock Analysis Report To read this article on Zacks.com click here......»»

Category: topSource: zacksOct 13th, 2021

Invesco DB Oil Fund (DBO) Hits a 52-Week High

The Invesco DB Oil Fund (DBO) hits a new 52-week high. Are more gains in store? Invesco DB Oil Fund DBO is probably a suitable pick for investors looking to gain momentum. The fund just hit a 52-week high and is up 135.5% from its 52-week low price of $6.29/share.Let’s take a look at the fund and its near-term outlook to get an insight into where it might be headed:DBO in FocusThe fund tracks changes, whether positive or negative, at the level of the DBIQ Optimum Yield Crude Oil Index Excess Return plus the interest income from the holdings of primarily U.S. Treasury securities and money-market income less expenses. It has AUM of $468.4 million and charges 77 basis points in annual fees.Why the Move?Oil prices crossed the $80-a-barrel mark amid the ongoing global power crisis. The price of crude reached a seven-year high level. Shrinking crude inventories, supply disruption in the Gulf of Mexico following a couple of hurricanes and surging fuel demand are pushing oil prices higher.Soaring coal and natural gas prices in Europe and Asia due to a supply-demand imbalance before the severe winter season is driving consumption of diesel and kerosene (according to a Bloomberg article). TheOrganization of the Petroleum Exporting Countries (OPEC) and a Russia-led group of oil producers, collectively called OPEC+ decided to raise production by 400,000 barrels a day each month. Also, the coronavirus vaccine rollout is gradually controlling the spread of the outbreak across the globe and augmenting demand for the fuel. This makes funds like DBO an attractive investment option.More Gains Ahead?It seems like the fund will remain strong with a positive weighted alpha of 97.66, which gives cues of a further rally. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Invesco DB Oil ETF (DBO): ETF Research Reports To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksOct 13th, 2021

PerkinElmer"s (PKI) Arm Gets FDA EUA Nod for Latest Assay

PerkinElmer's (PKI) unit receives FDA's EUA nod for its Anti-SARS-CoV-2 S1 Curve ELISA (IgG) that could aid in future understanding and provide insights on immune responses to SARS-CoV-2. PerkinElmer, Inc.’s PKI company, EUROIMMUN, recently announced that it has received FDA’s Emergency Use Authorization (EUA) for its Anti-SARS-CoV-2 S1 Curve ELISA (IgG). This assay enables the qualitative and semi-quantitative detection of IgG antibodies produced against the SARS-CoV-2 S1 antigen in human serum and plasma.This assay can run manually or utilizing the EUROLab Workstation ELISA, Sprinter XL and other third party ELISA platforms.In fact, clinical laboratories — certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA) — can start utilizing this ELISA for the detection of antibodies of the immunoglobulin class G immediately.It is worth mentioning that the Anti-SARS-CoV-2 S1 Curve ELISA (IgG), which is based on EUROIMMUN’s Anti-SARS-CoV-2 QuantiVac ELISA (IgG) (received CE mark in November 2020), ascertains the concentration of antibodies against the S1 domain of the spike protein that includes the receptor binding domain (RBD), indicating a crucial target antigen for virus neutralizing antibodies.This announcement is not only likely to provide a boost to PerkinElmer’s product portfolio but also bolster its Diagnostics business.More on the NewsPer management at EUROIMMUN, assays that help in detecting IgG antibodies are a crucial tool for the scientists and researchers who are working toward discovering the nature of SARS-CoV-2 and preventing the spread of other highly infectious viruses in the future.With the recent EUA, more laboratories will now have the capability to generate detailed insights on immunity that accelerate future antibody therapies and vaccines for COVID-19.It is important to mention here that the Anti-SARS-CoV-2 S1 Curve ELISA (IgG) is one of the numerous solutions in EUROIMMUN’s SARS-CoV-2 specific profile. This portfolio also comprises real-time PCR tests, an antigen detection assay and multiple antibody tests to name a few.Industry ProspectsPer a report by Grand View Research, the global antibodies market was estimated at $3.6 billion in 2020 and is projected to witness a CAGR of 6.4% from 2021 to 2028. Hence, this announcement comes at an opportune time for PerkinElmer’s company.Recent DevelopmentsIn September, PerkinElmer completed its buyout of BioLegend for a total consideration of approximately $5.25 billion. The latest buyout, which is historically the largest for the company, is expected to further expand its life science business into high-growth areas like cytometry, proteogenomics, multiplex assays, recombinant proteins, magnetic cell separation and bioprocessing.In August, the company announced the launch of its MaxSignal Mycotoxin Automation Bundle. Using the new assays and automation of this bundle, food safety QA managers and lab teams at grain processors, feed mills, pet food companies and contract labs can accurately and efficiently process up to 180 samples in less than 90 minutes.Other Notable ApprovalsSome other companies in the medical space that have received regulatory approvals in recent times are Abbott Laboratories ABT, Thermo Fisher Scientific Inc. TMO and QIAGEN N.V. QGEN.In September, Abbott received FDA approval for its Amplatzer Talisman PFO Occlusion System to treat patent foramen ovale (PFO) patients at risk of recurrent ischemic stroke. The next-generation Talisman system builds on the company’s industry-leading Amplatzer PFO Occluder.Again, in September, Thermo Fisher gained pre-market approval from the FDA for its Oncomine Dx Target Test as a companion diagnostic (CDx) to detect patients with epidermal growth factor receptor (EGFR) Exon20 insertion mutation-positive metastatic non-small cell lung cancer (mNSCLC), who are eligible of becoming candidates for EXKIVITY (mobocertinib).In August, QIAGEN announced the receipt of EUA from the FDA for its QIAreach SARS CoV-2 Antigen Test. This rapid portable test is designed to address the high-volume testing needs for SARS-CoV-2 antigens. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Abbott Laboratories (ABT): Free Stock Analysis Report Thermo Fisher Scientific Inc. (TMO): Free Stock Analysis Report PerkinElmer, Inc. (PKI): Free Stock Analysis Report QIAGEN N.V. (QGEN): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksOct 13th, 2021

Is 2021 Shaping Up to be Another Banner Year for Dealership M&As?

There has been a flurry of deal making in the auto retail space of late. Kerrigan Advisers predicts that 2021 would mark the biggest year for dealership M&A activities in decades. A wave of consolidation is sweeping across the auto retail industry. While vehicle purchases by consumers took a hit last year amid pandemic woes, buy-sell agreements among dealerships remained brisk. Per Kerrigan Advisors, a number of acquisitions in the auto retail space hit 289 last year, up 24% from 2019 levels, and marked the highest count in years.The momentum continues this year, with dealership transactions up 27% year over year to 144 in first-half 2021, per Kerrigan. The dealership consulting firm expects a surge in deal making across the industry in the second half. Kerrigan predicts 350 total transactions this year. That would set a new record, and make 2021 the biggest and most memorable year for dealership merger & acquisition (M&A) activities in decades.Key Deals So Far in 2021A flurry of megadeals was witnessed in the auto retail industry, particularly in the last month. On Sep 13, Group 1 Automotive GPI announced that it has inked an agreement to acquire Prime Automotive Group for about $880 million. Per the deal, which is expected to close by late November 2021, Group 1 will be purchasing 30 dealership locations and three collision centers throughout New England and the Mid-Atlantic region. The company has been a success in the North-Eastern United States for many years, and this opportunity will enable it to take advantage of the existing cost structure and further diversify its U.S. foothold. The acquisition will increase the company’s global dealership count to 220. Year to date, Group 1 has completed $570 million of acquired revenues, and the proposed transaction is expected to take its total acquired revenues to at least $2.4 billion.Ten days later, Sonic Automotive SAH announced its decision to buy RFJ Auto Partners in a deal worth $700 million. The acquisition seeks to catapult Sonic into the top-five biggest dealership groups (in terms of revenues) in the United States. RFJ Auto's portfolio of 33 dealerships across seven states generated $2.8 billion in revenues in 2020. The acquisition of RFJ Auto will add six new states (Idaho, Indiana, Missouri, Montana, New Mexico, and Washington) as well as five brands (Chrysler, Dodge, Jeep, Ram, and Mazda) to Sonic’s foothold and portfolio. Importantly, the deal is expected to add $3.2 billion to Sonic’s annual revenues. On Sep 29, Asbury Automotive Group ABG agreed to buy Larry H. Miller Dealerships, the eighth largest dealership in the United States, and Total Care Auto (TCA) in a $3.2-billion deal that is expected to close later this year. The Larry H. Miller Dealership acquisition seeks to add nearly $5.7 billion in expected annualized revenues, giving the company an edge to execute its five-year plan of generating $20 billion in annual revenues by 2025. Asbury claims to become the fourth-largest U.S. new vehicle retailer (in terms of revenues) after the deal closure. The acquired assets include 54 new and seven used vehicle dealerships as well as 11 collision centers. The buyout of TCA, a leading provider of service contracts and other vehicle protection products, will also enhance Asbury’s prospects.In April, Lithia Motors LAD — which has been on a long-standing buyout binge — announced the acquisition of Troy-based The Suburban Collection, which included 56 franchises, representing one of the biggest acquisitions by the auto retailer. The deal strengthened Lithia’s position in the North Central region and is expected to add $2.4 billion in the firm’s annualized revenues. Given Lithia’s spree of big and small deals this year, its total annualized revenues acquired in 2021 summed $6.2 billion.In April, AutoNation AN also announced a deal to purchase 11 stores and a collision center from Peacock Automotive Group. The deal marked the first franchised dealership buyout since 2018 and will add $380 million in annual revenues. The acquisition has expanded AutoNation's footprint from coast to coast to more than 325 locations. What’s Behind This M&A Frenzy?The process of buying cars has undergone a digital transformation, with online sales getting ever so popular, thanks to the pandemic. Auto dealers are ramping up their digital capabilities to make deals with customers and arrange for home deliveries of vehicles. The race to invest vast sums in the e-commerce platform has gathered steam and companies that won’t be making the necessary efforts to step up their online game will be left behind. Retailers are thus vying for a wider reach and greater scale amid the changing operating dynamics of the industry.In light of this scenario, big retailers that are flush with cash are seeking to scoop up smaller rivals in a hope that an increase in scale would help them lead digital transformation and boost competitive advantage. Dealers not only need to operate service departments with expensive and sophisticated equipment but are also supposed to have dual systems to service electric as well as conventional vehicles. As such, capital requirements have increased and the relatively smaller companies would rather accept the takeover proposal than spend huge sums of money to reorient their business model. It’s not just the big businesses taking over the smaller ones. Even Larry Miller chose to be acquired, realizing the importance of scale and synergies, and that it would be better poised to reach new heights as part of a bigger organization than its own.The dealership business is largely fragmented and dominated by small, individually-held operations. Per Kerrigan, the top 50 largest dealerships (in terms of new vehicle sales) in the United States accounted for just 16% of the nation’s total new vehicle sales last year. Some dealers are of the view that the only way to survive long term is to get bigger. Then of course, there are commercial, financial and operating synergy gains from such deals. In addition, a highly competitive auto retail market is resulting in lesser-known and smaller dealer groups exiting the industry.One of the dealership consulting firms Haig Partners sees Lithia’s deep focus on acquisitions as one of the catalysts for increased deal making across the industry. As we know, the company announced a five-year plan in July 2020 to generate $50 billion in revenues and $50 in earnings per share, primarily through acquisitions. Quoting Alan Haig, the president of Haig, “I think the CEOs of other public retailers said whoa that strategy makes a lot of sense.”  Also, increasing dealership profitability and better access to capital have further boosted M&A activities since late 2020.Merger Mania is Unlikely to Slow DownAsbury’s CEO Hult eyes more consolidation in the industry. The company remains committed to strategic buyouts that align with its customer-centric working model. Lithia has already been on an acquisition tear, in sync with its five-year plans. Sonic’s CEO Davi Smith also expects M&A activities to continue picking up. Certainly, a new era of dealership consolidation is underway. Erin Kerrigan, the MD of Kerrigan, is of the opinion, “that this is just the beginning of mega-transactions being announced over the next 12 months, assuming that the financial markets continue to support the financing of these kinds of acquisitions.” Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report AutoNation, Inc. (AN): Free Stock Analysis Report Group 1 Automotive, Inc. (GPI): Free Stock Analysis Report Sonic Automotive, Inc. (SAH): Free Stock Analysis Report Asbury Automotive Group, Inc. (ABG): Free Stock Analysis Report Lithia Motors, Inc. (LAD): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksOct 13th, 2021

What"s in Store for MarketAxess" (MKTX) Earnings in Q3?

MarketAxess' (MKTX) Q3 earnings might decline due to higher expenses. MarketAxess Holdings Inc. MKTX is expected to witness a decline in earnings from the year-ago reported figure when it reports third-quarter 2021 earnings results on Oct 20, 2021.Estimate TrendThe consensus estimate for September-quarter earnings of this operator of bond trading platforms is pegged at $1.51 per share, which indicates a decrease of 15.2% from the prior-year period’s reported number.The consensus mark for revenues stands at $170.92 million, suggesting a 4.21% rise from the year-ago quarter’s reported figure.Factors to WatchMarketAxess already released total trading volume of $1.53 trillion for the third quarter, which was up 13% year over year but down 1.9%, sequentially.MarketAxess earns commission and fees revenues on the bond trading executed on its platforms. Thus, increase in trading volumes is expected to have buoyed commission and fees revenues in the September quarter, which constitute 90% of the company’s top line.Margins are likely to have been stressed by high expenses. The company expects total expenses for 2021 in the range of $370-$386, indicating a rise from the previous projection of $362-$382 million.Earnings Surprise HistoryThe company’s earnings beat estimates in three of the last four quarters (missed the mark in one), the average surprise being 2.75%. This is depicted in the chart below:MarketAxess Holdings Inc. Price and EPS Surprise MarketAxess Holdings Inc. price-eps-surprise | MarketAxess Holdings Inc. QuoteHere is what our quantitative model predicts:Our proven model does not predict an earnings beat for MarketAxess this time around. The combination of a positive  Earnings ESP  and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat, which is not the case here. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.Earnings ESP:  MarketAxess has an Earnings ESP of -10.72%.Zacks Rank:  MarketAxess currently has a Zacks Rank #5 (Strong Sell).Stocks to ConsiderSome stocks worth considering with the apt combination of elements to surpass estimates this reporting cycle are as follows:Cboe Global Markets, Inc. CBOE has an Earnings ESP of +3.77% and a Zack Rank #2, presently.  You can see  the complete list of today’s Zacks #1 Rank stocks here.Tradeweb Markets Inc. TW   has an Earnings ESP of +2.63% and a Zacks Rank #3, presently.Intercontinental Exchange Inc. ICE has an Earnings ESP of +2.99% and a Zacks Rank of #3, presently.  Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Intercontinental Exchange Inc. (ICE): Free Stock Analysis Report Cboe Global Markets, Inc. (CBOE): Free Stock Analysis Report Tradeweb Markets Inc. (TW): Free Stock Analysis Report MarketAxess Holdings Inc. (MKTX): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksOct 13th, 2021

Should You Invest in ETFs Tracking the Latest Oil Rally?

Take a look at some ETFs that can benefit from the latest rally in oil prices due to growing fuel consumption and OPEC+'s decision to increase fuel production gradually. Oil prices have surpassed the $80-a-barrel mark amid the ongoing global power crisis. The price of crude has reached a seven-year high level. Notably, shrinking crude inventories, supply disruption in the Gulf of Mexico following a couple of hurricanes and surging fuel demand have been pushing oil prices higher. Going on, soaring coal and natural gas prices in Europe and Asia due to a supply-demand imbalance before the severe winter season is driving consumption of diesel and kerosene (according to a Bloomberg article).The American crude benchmark has surged about 30% since mid-August due to the worsening energy crisis. As mentioned in a Bloomberg article, Saudi Aramco believes that there has been a rise in oil demand by around 500,000 barrels/day due to the limited gas supply.Meanwhile, the Organization of the Petroleum Exporting Countries (OPEC) and a Russia-led group of oil producers, collectively called OPEC+, have decided to raise production by 400,000 barrels a day each month. Notably, the group has decided to adhere to its previously agreed plan of slowly returning production to pre-pandemic levels. Market pundits were estimating higher production rise from OPEC+ considering the oil price’s consistent rise.Commenting on the market condition, Daniel Hynes, a senior commodity strategist at Australia & New Zealand Banking Group Ltd, has said that “OPEC’s decision to hold back from a bigger than scheduled increase in output is likely to see the market tighten further in the fourth quarter,” per a Bloomberg article.The coronavirus vaccine rollout is gradually helping control the spread of the outbreak across the globe. The optimism surrounding the gradual reopening of global economies and increasing demand is painting a rosy picture for cyclical sectors.The progress in coronavirus vaccine rollout presents a strong case,favoring a faster return to normalcy and economic recovery. The FDA has approved the emergency use of a booster dose of the Pfizer Inc. (PFE) and BioNTech SE (BNTX) COVID-19 vaccine. President Joe Biden has also outlined an effective plan to accelerate the vaccination rate and control the coronavirus outbreak. He has made it mandatory for federal employees to get COVID-19 vaccination, per a CNBC article.In another positive development, the optimism surrounding the news highlighting positive updates on Merck (MRK) and Ridgeback Biotherapeutics’ investigational oral antiviral medicine, molnupiravir, can support the sector. The update supports the spaces expected to gain from the reopening of economies as molnupiravir will help fight against COVID-19 if approved by the FDA.Oil ETFs That Might GainAgainst this backdrop, investors can take a closer look at the oil commodity space and its related ETFs (see all Energy ETFs here).United States Oil Fund USOThe United States Oil Fund’s investment objective is for the daily changes, in percentage terms, of its shares’ net asset value (NAV) to reflect the daily changes, in percentage terms, of the spot price of light sweet crude oil delivered to Cushing, OK, as measured by the daily changes in the Benchmark Oil Futures Contract (read: ETF Asset Report of September).AUM: $2.63 billionTotal Expense Ratio: 0.83%Invesco DB Oil Fund DBOThe fund tracks changes, whether positive or negative, in the level of the DBIQ Optimum Yield Crude Oil Index Excess Return plus the interest income from the holdings of primarily U.S. Treasury securities and money-market income-less expenses (read: Tough Time for Energy ETFs on Oversupply Concerns?).AUM: $461.6 millionTotal Expense Ratio: 0.77%United States Brent Oil Fund BNOThe fund tracks the daily price movement of Brent crude oil (read: 5 Winning Global ETFs of First Nine Months of 2021).AUM: $247 millionTotal Expense Ratio: 1.13%United States 12 Month Oil Fund USLThe fund replicates with possible accuracy the price movements of West Texas Intermediate light, sweet crude oil.AUM: $152.6 millionTotal Expense Ratio: 0.88% Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report United States Oil ETF (USO): ETF Research Reports Invesco DB Oil ETF (DBO): ETF Research Reports United States 12 Month Oil ETF (USL): ETF Research Reports United States Brent Oil ETF (BNO): ETF Research Reports To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksOct 13th, 2021

Growing COVID-19 Testing Demand to Boost Abbott"s (ABT) Q3 Earnings

Through July to September, Abbott's (ABT) Diagnostic business is likely to have benefited from the significant surge in the new COVID-19 case counts. Abbott Laboratories ABT is slated to report third-quarter 2021 results on Oct 20, before market open.In the last reported quarter, the company posted a negative earnings surprise of 15.84%. Over the trailing four quarters, its earnings have exceeded the Zacks Consensus Estimate on three occasions and missed on one, the average beat being 7.65%.Let's see how things have shaped up prior to this announcement.Factors at PlayFrom May through July, a significant reduction in the number of COVID-19 cases in the United States and other major developed countries accelerated the roll-out of the COVID-19 vaccine globally (with the U.S. health authority’s restrictions for testing on fully-vaccinated individuals), which hurt Abbott’s sales considerably.In such a situation, Abbott had to lower its 2021 guidance in anticipation of the considerable reduction in the recent and projected COVID-19 Diagnostic testing demand.However, the later months of the third quarter saw an entire transformation of the scenario — all thanks to the emergence of the more lethal and more contagious Delta variant of COVID-19. Accordingly, like the other industry players, through July to September, the company‘s Diagnostics business is likely to have benefited from the significant surge in the new COVID-19 case count.As a result, the company is expected to report sequentially stronger diagnostics results in the third quarter.Within Nutrition, from the beginning of the pandemic till the last reported quarter, Abbott gained consistently in terms of adult nutrition products sales. In the third quarter too, the company is anticipated to have registered stellar U.S. and international growth in Ensure (adult complete and balanced nutrition brand) and Glucerna (diabetes nutrition brand). According to the company, the two factors that are driving the adult nutrition growth rate are — the new users entering the category in this period and the existing customers increasing their usage.Abbott Laboratories Price and EPS Surprise Abbott Laboratories price-eps-surprise | Abbott Laboratories QuoteWithin pediatric nutrition, the company, however, witnessed a significant lag in sales from the start of the pandemic till April 2021. We note that paediatric healthcare took a backseat through these months as the earlier variants of COVID-19 did not impact child health at all. Nonetheless, sales improved in the second quarter on a strong demand for Pedialyte, the global rehydration brand of Abbott, driven by the increased investment in direct consumer promotion. With a number of researches coming up on the findings that the new variants of COVID-19 are expected to harm child health more (the still unvaccinated band of the world population), this uptrend within pediatric nutrition is likely to have continued in the third quarter as well.Abbott’s other consumer facing businesses, which include diabetes care and established pharmaceuticals, have been catching up pace backed by a continued strong cadence of new product instructions. This uptrend is likely to have majorly contributed to the company third-quarter performance.Within Established Pharmaceuticals Division (EPD), the company has been witnessing visible signs of a rebound, reflecting sequential improvement based on its stable business model. New product launches across the key emerging markets have been majorly boosting the EPD business in the recent months. The performance in the third quarter is likely to have been driven by growth in India and Brazil, apart from the United States where the COVID-19 cases have been shooting up. The business is anticipated to have grown in these regions where patients are seeking branded generic medicinesRevenues are likely to have improved in the company’s Diabetes Care business, as it has been on a substantially strong growth trajectory in recent times. Abbott has been in the limelight for developments in its flagship, sensor-based continuous glucose monitoring system, widely known as the FreeStyle Libre System.In 2020, the company received the U.S. approval for Freestyle Libre 2 (an integrated continuous glucose monitoring or iCGM system for adults and children), the CE Mark for Libre 3 (integrates Libre's accuracy and performance into the world's smallest fitness disposable sensor) and Libre Sense Glucose Sport (which is Abbott’s initial step in a very intentional approach to pursue mass market biosensor opportunities beyond diabetes).These developments are anticipated to have led to full-quarter contributions to the Diabetes Care business’ top line during the third quarter.Abbott, in July, projected third-quarter 2021 reported earnings per share from continuing operations of at least 90 cents. However, this took into consideration the company’s apprehension of a sequential reduction in the COVID-19 testing-related sales compared to the second quarter.EstimatesFor third-quarter 2021, the Zacks Consensus Estimate for total revenues of $9.43 billion indicates a 6.5% rise from the prior-year quarter’s reported figure. The consensus mark for earnings is pegged at 92 cents, suggesting a 6.1% decline year on year.Earnings WhispersPer our proven model, a stock with the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold), has higher chances of beating estimates. That is not the case here as you can see:Earnings ESP: Abbott has an Earnings ESP of 0.00%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.Zacks Rank: It currently carries a Zacks Rank #3.Stocks Worth a LookHere are a few medical stocks worth considering, as these have the right combination of elements to beat on earnings this reporting cycle.UnitedHealth Group Incorporated UNH has an Earnings ESP of +1.95% and carries a Zacks Rank of 2, currently. The company is slated to release third-quarter 2021 results on Oct 14.  You can see the complete list of today’s Zacks #1 Rank stocks here.Quest Diagnostics Incorporated DGX has an Earnings ESP of +12.10% and holds a Zacks Rank of 2, at present. The company is scheduled to report quarterly numbers on Oct 21.West Pharmaceutical Services, Inc. WST has an Earnings ESP of +1.93% and is a Zacks #2 Ranked stock. The company will announce third-quarter figures on Oct 28. Zacks Names "Single Best Pick to Double" From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all. You know this company from its past glory days, but few would expect that it's poised for a monster turnaround. Fresh from a successful repositioning and flush with A-list celeb endorsements, it could rival or surpass other recent Zacks' Stocks Set to Double like Boston Beer Company which shot up +143.0% in a little more than 9 months and Nvidia which boomed +175.9% in one year.Free: See Our Top Stock and 4 Runners Up >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Abbott Laboratories (ABT): Free Stock Analysis Report UnitedHealth Group Incorporated (UNH): Free Stock Analysis Report Quest Diagnostics Incorporated (DGX): Free Stock Analysis Report West Pharmaceutical Services, Inc. (WST): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research.....»»

Category: topSource: zacksOct 13th, 2021